Find Hetacillin Potassium manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Natacillin, 5321-32-4, Potassium hetacillin, Versapen-k, Hetacillin (potassium), Versatrex
Molecular Formula
C19H22KN3O4S
Molecular Weight
427.6  g/mol
InChI Key
QRSPJBLLJXVPDD-XFAPPKAWSA-M
FDA UNII
95PFX5932Y

Hetacillin Potassium
Hetacillin Potassium is the potassium salt of hetacillin, a semi-synthetic penicillin antibiotic with bactericidal activity. Hetacillin is a prodrug that is converted to ampicillin via esterases. Ampicillin binds to and inactivated penicillin-binding proteins (PBPs) located on the inner membrane of the bacterial cell wall, thereby preventing the cross-linkage of peptidoglycans, which are critical components of the bacterial cell wall. This leads to an interruption of the bacterial cell wall and causes bacterial cell lysis.
1 2D Structure

Hetacillin Potassium

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
potassium;(2S,5R,6R)-6-[(4R)-2,2-dimethyl-5-oxo-4-phenylimidazolidin-1-yl]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
2.1.2 InChI
InChI=1S/C19H23N3O4S.K/c1-18(2)13(17(25)26)21-15(24)12(16(21)27-18)22-14(23)11(20-19(22,3)4)10-8-6-5-7-9-10;/h5-9,11-13,16,20H,1-4H3,(H,25,26);/q;+1/p-1/t11-,12-,13+,16-;/m1./s1
2.1.3 InChI Key
QRSPJBLLJXVPDD-XFAPPKAWSA-M
2.1.4 Canonical SMILES
CC1(C(N2C(S1)C(C2=O)N3C(=O)C(NC3(C)C)C4=CC=CC=C4)C(=O)[O-])C.[K+]
2.1.5 Isomeric SMILES
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)N3C(=O)[C@H](NC3(C)C)C4=CC=CC=C4)C(=O)[O-])C.[K+]
2.2 Other Identifiers
2.2.1 UNII
95PFX5932Y
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. Natacillin

2. 5321-32-4

3. Potassium Hetacillin

4. Versapen-k

5. Hetacillin (potassium)

6. Versatrex

7. Hetacin-k

8. Chebi:34789

9. 95pfx5932y

10. Nsc-757046

11. Potassium 6-(2,2-dimethyl-5-oxo-4-phenyl-1-imidazolidinyl)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate

12. Potassium;(2s,5r,6r)-6-[(4r)-2,2-dimethyl-5-oxo-4-phenylimidazolidin-1-yl]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate

13. Hetacin-k (veterinary)

14. H-k Mastitis (veterinary)

15. Unii-95pfx5932y

16. Einecs 226-182-3

17. Hetacin-k (tn)

18. Hetacillin Potassium [usan:usp:jan]

19. Hetacillin Potassium Salt

20. Schembl192601

21. Chembl1201121

22. Hetacillin Potassium (jan/usan)

23. Hetacillin Potassium [jan]

24. Hetacillin Potassium [usan]

25. Hetacillin Potassium [mart.]

26. Hetacillin Potassium [who-dd]

27. Hetacillin Potassium Salt [mi]

28. Cs-4871

29. Nsc 757046

30. Hetacillin Potassium [green Book]

31. Hetacillin Potassium [orange Book]

32. Hy-16251

33. D02203

34. Q27116274

35. Potassium 6beta-[(4r)-2,2-dimethyl-5-oxo-4-phenylimidazolidin-1-yl]penicillanate

36. 26939-80-0

37. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 6-(2,2-dimethyl-5-oxo-4-phenyl-1-imidazolidinyl)-3,3-dimethyl-7-oxo-, Monopotassium Salt, (2s-(2.alpha.,5.alpha.,6.beta.(s*)))-

38. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 6-(2,2-dimethyl-5-oxo-4-phenyl-1-imidazolidinyl)-3,3-dimethyl-7-oxo-, Monopotassium Salt, (2s-(2alpha,5alpha,6beta(s*)))-

39. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 6-(2,2-dimethyl-5-oxo-4-phenyl-imidazolinyl)-3,3-dimethyl-7-oxo-, Monopotassium Salt

40. 4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid,6-[(4r)-2,2-dimethyl-5-oxo-4-phenyl-1-imidazolidinyl]-3,3-dimethyl-7-oxo-,potassium Salt(1:1),(2s,5r,6r)-

41. Potassium (2s,5r,6r)-6-[(4r)-2,2-dimethyl-5-oxo-4-phenylimidazolidin-1-yl]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate

42. Potassium (2s-(2alpha,5alpha,6beta(s*)))-6-(2,2-dimethyl-5-oxo-4-phenylimidazolidin-1-yl)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate

43. Potassium 6beta-[(4r)-2,2-dimethyl-5-oxo-4-phenylimidazolidin-1-yl]-2,2-dimethylpenam-3alpha-carboxylate

2.4 Create Date
2008-02-05
3 Chemical and Physical Properties
Molecular Weight 427.6 g/mol
Molecular Formula C19H22KN3O4S
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count6
Rotatable Bond Count3
Exact Mass427.09680885 g/mol
Monoisotopic Mass427.09680885 g/mol
Topological Polar Surface Area118 Ų
Heavy Atom Count28
Formal Charge0
Complexity695
Isotope Atom Count0
Defined Atom Stereocenter Count4
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty